These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32693162)

  • 1. Scientific diligence for oncology drugs: a pharmacology, translational medicine and clinical perspective.
    Parasrampuria DA; Bandekar R; Puchalski TA
    Drug Discov Today; 2020 Oct; 25(10):1855-1864. PubMed ID: 32693162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical pharmacokinetic/pharmacodynamic modeling and simulation in the pharmaceutical industry: an IQ consortium survey examining the current landscape.
    Schuck E; Bohnert T; Chakravarty A; Damian-Iordache V; Gibson C; Hsu CP; Heimbach T; Krishnatry AS; Liederer BM; Lin J; Maurer T; Mettetal JT; Mudra DR; Nijsen MJ; Raybon J; Schroeder P; Schuck V; Suryawanshi S; Su Y; Trapa P; Tsai A; Vakilynejad M; Wang S; Wong H
    AAPS J; 2015 Mar; 17(2):462-73. PubMed ID: 25630504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective.
    Wong H; Bohnert T; Damian-Iordache V; Gibson C; Hsu CP; Krishnatry AS; Liederer BM; Lin J; Lu Q; Mettetal JT; Mudra DR; Nijsen MJMA; Schroeder P; Schuck E; Suryawanshi S; Trapa P; Tsai A; Wang H; Wu F
    Drug Discov Today; 2017 Oct; 22(10):1447-1459. PubMed ID: 28476536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teaching Targeted Drug Discovery and Development to Healthcare Professionals.
    Fruchter R; Ahmad M; Pillinger M; Galeano C; Cronstein BN; Gold-von Simson G
    Clin Transl Sci; 2018 May; 11(3):277-282. PubMed ID: 29110398
    [No Abstract]   [Full Text] [Related]  

  • 5. How to rekindle drug discovery process through integrative therapeutic targeting?
    Vaidya A; Roy A; Chaguturu R
    Expert Opin Drug Discov; 2018 Oct; 13(10):893-898. PubMed ID: 30146919
    [No Abstract]   [Full Text] [Related]  

  • 6. How to utilize academic research efforts in cancer drug discovery.
    Bérubé G
    Expert Opin Drug Discov; 2019 Apr; 14(4):331-334. PubMed ID: 30784328
    [No Abstract]   [Full Text] [Related]  

  • 7. Rethinking 'academic' drug discovery: the Manchester Institute perspective.
    Jordan AM; Waddell ID; Ogilvie DJ
    Drug Discov Today; 2015 May; 20(5):525-35. PubMed ID: 25542353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing and sustaining India's capacity for preclinical drug discovery.
    Lewis DI; Patel BK; Kumar BD; Medhi B
    Indian J Pharmacol; 2018; 50(5):225-226. PubMed ID: 30636824
    [No Abstract]   [Full Text] [Related]  

  • 9. How Well Are We Applying Quantitative Methods to Reverse Translation to Inform Early Clinical Development?
    Heatherington AC; Kasichayanula S; Venkatakrishnan K
    Clin Pharmacol Ther; 2018 Feb; 103(2):174-176. PubMed ID: 29274086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
    Chung TD
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of the attrition of drug candidates from four major pharmaceutical companies.
    Waring MJ; Arrowsmith J; Leach AR; Leeson PD; Mandrell S; Owen RM; Pairaudeau G; Pennie WD; Pickett SD; Wang J; Wallace O; Weir A
    Nat Rev Drug Discov; 2015 Jul; 14(7):475-86. PubMed ID: 26091267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a Dynamic Map for Learning, Communicating, Navigating, and Improving Therapeutic Development.
    Wagner JA; Dahlem AM; Hudson LD; Terry SF; Altman RB; Gilliland CT; DeFeo C; Austin CP
    Clin Transl Sci; 2018 Mar; 11(2):166-174. PubMed ID: 29271559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic risk identification and assessment using a new risk map in pharmaceutical R&D.
    Schuhmacher A; Brieke C; Gassmann O; Hinder M; Hartl D
    Drug Discov Today; 2021 Dec; 26(12):2786-2793. PubMed ID: 34229082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. canSAR: update to the cancer translational research and drug discovery knowledgebase.
    Mitsopoulos C; Di Micco P; Fernandez EV; Dolciami D; Holt E; Mica IL; Coker EA; Tym JE; Campbell J; Che KH; Ozer B; Kannas C; Antolin AA; Workman P; Al-Lazikani B
    Nucleic Acids Res; 2021 Jan; 49(D1):D1074-D1082. PubMed ID: 33219674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. True alignment of preclinical and clinical research to enhance success in CNS drug development: a review of the current evidence.
    Goetghebeur PJ; Swartz JE
    J Psychopharmacol; 2016 Jul; 30(7):586-94. PubMed ID: 27147593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The state of the art in secondary pharmacology and its impact on the safety of new medicines.
    Brennan RJ; Jenkinson S; Brown A; Delaunois A; Dumotier B; Pannirselvam M; Rao M; Ribeiro LR; Schmidt F; Sibony A; Timsit Y; Sales VT; Armstrong D; Lagrutta A; Mittlestadt SW; Naven R; Peri R; Roberts S; Vergis JM; Valentin JP
    Nat Rev Drug Discov; 2024 Jul; 23(7):525-545. PubMed ID: 38773351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from candidate drug attrition.
    Empfield JR; Leeson PD
    IDrugs; 2010 Dec; 13(12):869-73. PubMed ID: 21154145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D human liver spheroids for translational pharmacology and toxicology.
    Ingelman-Sundberg M; Lauschke VM
    Basic Clin Pharmacol Toxicol; 2022 Jan; 130 Suppl 1():5-15. PubMed ID: 33872466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An industrial approach towards solid dosage development for first-in-human studies: Application of predictive science and lean principles.
    Kalaria DR; Parker K; Reynolds GK; Laru J
    Drug Discov Today; 2020 Mar; 25(3):505-518. PubMed ID: 31926318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges.
    Geerts H; Wikswo J; van der Graaf PH; Bai JPF; Gaiteri C; Bennett D; Swalley SE; Schuck E; Kaddurah-Daouk R; Tsaioun K; Pelleymounter M
    CPT Pharmacometrics Syst Pharmacol; 2020 Jan; 9(1):5-20. PubMed ID: 31674729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.